Key result
Cardiopulmonary exercise testing was feasible in 130 of 131 patients with asymptomatic or equivocal aortic stenosis, with high reproducibility and no cardiovascular deaths at 1 year.
Why the study?
Is cardiopulmonary exercise testing feasible, reproducible, and safe for assessing exercise physiology and guiding treatment in patients with asymptomatic or equivocal symptomatic aortic stenosis?
Observational (n=131)
Is cardiopulmonary exercise testing feasible, reproducible, and safe for assessing exercise physiology and guiding treatment in patients with asymptomatic or equivocal symptomatic aortic stenosis?
Cardiopulmonary exercise testing is a feasible, reproducible, and safe tool for evaluating hemodynamic compromise and guiding valve replacement decisions in patients with asymptomatic or equivocal symptomatic aortic stenosis.
Answers are grounded in this paper and cite their sources.
CPET feasible with high reproducibility in asymptomatic aortic stenosis; leaves open its prognostic role in larger studies.
OBJECTIVE: The aim of this study was to determine the feasibility, reproducibility, safety and information obtained on exercise physiology from cardiopulmonary exercise testing (CPX) in patients with aortic stenosis. METHODS: Patients with an aortic valve area (AVA) <1.3 cm2 who were judged asymptomatic or equivocal symptomatic underwent CPX and an inert gas rebreathing test. Only those where comprehensive evaluation of CPX results indicated haemodynamic compromise from aortic stenosis were referred for valve replacement. RESULTS: The mean patient age was 72 (±9) years; an AVA index <0.6 cm2/m2 and equivocal symptomatic status were found in 90 and 70%, respectively. CPX was feasible in 130 of the 131 patients. The coefficients of repeatability by test-retest were 5.4% (pVO2) and 4.6% (peak O2 pulse). A pVO2 <83% of the expected was predicted by a lower stroke volume at exercise, lower peak heart rate and FEV1, and higher VE/VCO2, but not by AVA index. Equivocal symptomatic status and a low gradient but high valvulo-arterial impedance were associated with a lower pVO2, but not with an inability to increase stroke volume. In total, 18 patients were referred for valve replacement. At 1 year, no cardiovascular deaths had occurred. CONCLUSIONS: CPX was feasible and reproducible and provided comprehensive data on exercise physiology. A CPX-guided treatment strategy was safe up to 1 year.
No takes yet. Share an insight, caveat, or question.
Le et al. (2015) conducted an observational in Asymptomatic or equivocal symptomatic aortic stenosis (n=131). Cardiopulmonary exercise testing (CPX) was evaluated on Feasibility of CPX. Cardiopulmonary exercise testing was feasible in 130 of 131 patients with asymptomatic or equivocal aortic stenosis, with high reproducibility and no cardiovascular deaths at 1 year.
Synapse has enriched 10 related papers. Consider them for comparative context: